Angiotensin-converting enzyme inhibitors after renal transplantation (Q46613237)

23 December 2017

title

Angiotensin-converting enzyme inhibitors after renal transplantation (English)

1 reference

23 December 2017

author name string

P Bravo

1

1 reference

23 December 2017

J Felgueiras

2

1 reference

23 December 2017

C Santos

3

1 reference

23 December 2017

C Oliveira

4

1 reference

23 December 2017

P Ponce

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

23 December 2017

Transplantation Proceedings

published in

1 reference

23 December 2017

volume

40

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

740-742

1 reference

23 December 2017

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Angiotensin converting enzyme inhibition in chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

Hypertension, antihypertensive agents and outcomes following renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.014

10.1016/J.TRANSPROCEED.2008.03.014

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017